Showing results (351-360 of 599) with videos related to

Sort By:
Pageof 60
Lancet (London, England)|June 26, 2023
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialJuan P Frias, Srikanth Deenadayalan, Lars Erichsen, et al.
Arthritis and Rheumatism|August 1, 2007
Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathyMuhammad S Soyfoo, Carine De Vriese, Huguette Debaix, et al.
Diabetes|July 28, 2005
Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cellsConny A Gysemans, Laurence Ladrière, Hanne Callewaert, et al.
Annals of Internal Medicine|January 18, 2012
High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trialAn Lehouck, Chantal Mathieu, Claudia Carremans, et al.
Diabetes, Obesity & Metabolism|September 15, 2022
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetesAthena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, et al.
Lancet (London, England)|September 13, 2024
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trialRichard M Bergenstal, Ruth S Weinstock, Chantal Mathieu, et al.
Health and Quality of Life Outcomes|December 28, 2013
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational studyMatthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, et al.
Biomolecules|October 27, 2022
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes DevelopmentKailash Singh, Orian Bricard, Jeason Haughton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signalingPeter W Hellings, Ahmad Kasran, Dominique Bullens, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2013
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extensionChantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, et al.
Pageof 60